🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

27 recruiting trials

for Pulmonary Tuberculosis (TB)

A Study of Quabodepistat-containing Regimens for the Treatment of Drug-resistant Pulmonary Tuberculosis NCT07209761Phase 342 sites📍 Beijing📍 Fuzhou📍 Shenzhen Otsuka Pharmaceutical Development & Commercialization, Inc. · Tests: Bedaquiline, Quabodepistat, Pretomanid, Moxifloxacin, Linezolid Safety and Efficacy of Ear Acupuncture for Antituberculosis Drug-Related Nausea and Vomiting NCT07271225NA1 site📍 Jakarta Universitas Indonesia · Tests: Press Needle, Sham Press Needle Doxycycline Host-directed Therapy to Improve Lung Function and Decrease Tissue Destruction in Pulmonary Tuberculosis NCT05473520Phase 36 sites📍 Kota Kinabalu📍 Kota Kinabalu📍 Kota Kinabalu National University Hospital, Singapore · Tests: Doxycycline, Placebo ID93+GLA-SE Vaccine Against Tuberculosis in Older Adults Aged 55-74 NCT06714513Phase 14 sites📍 Gwangmyeong📍 Seoul📍 Seoul Quratis Inc. · Tests: QTP101, Placebo Parent Study Name: Pulmonary Rehabilitation to Reduce Post-Tuberculosis Morbidity (TB Pure) NCT07164742NA2 sites📍 Mangalore📍 Pune Johns Hopkins University · Tests: 8 week (short arm) Intervention - pulmonary rehabilitation, 24 week (long arm) Intervention - pulmonary rehabilitation LIFE-TB ; Long-Term Impacts on Lung Health and Life After Tuberculosis in Korea NCT06946784n/a1 site📍 Seoul Yonsei University Channa Striata and Curcuma Domestica Supplementation in Patients With Active Pulmonary Tuberculosis NCT07887724NA2 sites📍 Medan📍 Medan DINA KEUMALA SARI · Tests: CHANA STRIATA AND CURCUMA, Maltodextrin (Placebo) Improving the Outcomes of Children With Tuberculosis Through Innovative Diagnostics and Treatment Monitoring NCT06815588n/a1 site📍 Bucharest Research Center Borstel Shortened Regimen for Drug-susceptible TB in Children NCT06253715Phase 39 sites📍 Chennai📍 Pune📍 Bandung Johns Hopkins University · Tests: Isoniazid, Rifampin, Pyrazinamide, Ethambutol, Rifapentine A PAN-USR TB Multi-Center Trial NCT06905522Phase 33 sites📍 Beijing📍 Shenzhen📍 Ürümqi Shenzhen Third People's Hospital · Tests: Bedaquiline (B), Sitafloxacin (S), Linezolid (L), Pyrazinamide (Z), Isoniazid (H) A Phase III Study of Oral Sudapyridine (WX-081) Tablets in Rifampicin-Resistant Pulmonary Tuberculosis Patients NCT05824871Phase 32 sites📍 Beijing📍 Beijing Shanghai Jiatan Pharmatech Co., Ltd · Tests: Sudapyridine, Bedaquiline Sorfequiline-based Regimens in Adults With Newly Diagnosed Drug-sensitive Pulmonary TB NCT07672405Phase 212 sites📍 Wentworth📍 Port Elizabeth📍 Soshanguve Global Alliance for TB Drug Development · Tests: sorfequiline, Pretomanid, Linezolid ATORvastatin in Pulmonary TUBerculosis NCT06199921Phase 28 sites📍 Zaria📍 Katsina📍 Keffi Obafemi Awolowo University Teaching Hospital · Tests: Atorvastatin 20mg, Atorvastatin 40mg, Atorvastatin 60mg, Fixed dose combination of Rifampicin (R) Isoniazid (H) Pyrazin… Novel Triple-dose Tuberculosis Retreatment Regimen NCT04260477Phase 31 site📍 Niamey Institute of Tropical Medicine, Belgium · Tests: 6EH³R³Z, 6EHRZ Paediatric Post-TB Pulmonary Rehab Study NCT07097961NA1 site📍 Kampala University of Iowa · Tests: Pulmonary Rehabilitation ATORvastatin in Pulmonary TUBerculosis: a POPulation PharmacoKinetics -PharmacoDynamics Sub-study (ATORTUB popPK-PD) NCT07303699Phase 23 sites📍 Zaria📍 Katsina📍 Ile-Ife Obafemi Awolowo University Teaching Hospital · Tests: Atorvastatin 20 mg, Atorvastatin 40 mg, Atorvastatin 60 mg, Fixed dose combination of Rifampicin (R) Isoniazid (H) Pyra… A Confirmatory Trial of Adjunctive NAC to Prevent Post Tuberculosis Lung Disease NCT06909799NA1 site📍 Fajara The Aurum Institute NPC · Tests: N-Acetyl Cysteine (NAC), Standard TB treatment Platform Assessing Regimens and Durations In a Global Multisite Consortium for TB NCT06114628Phase 211 sites📍 Chisinau📍 Cape Town📍 Cape Town University College, London · Tests: Ganfeborole, BTZ-043, Bedaquiline (B), Delamanid (D), Pretomanid (Pa) BRIGHT-Child TB: Short-Course Treatment for Non-Severe Pulmonary Tuberculosis in Children NCT07893444Phase 213 sites📍 Fuzhou📍 Guangzhou📍 Guiyang Huashan Hospital · Tests: 4-month FDC-based regimen, 3-month BDCZ regimen, Standard 6-month treatment regimen Immunogenicity of COVID-19 Vaccines in Tuberculosis Patients NCT05571735n/a1 site📍 Mae Ramat University of Oxford · Tests: Pfizer-BioNTech COVID-19 vaccine, AstraZeneca vaccine, Janssen Ad26.COV2.S COVID-19 vaccine Digital Health Intervention to Improve TPT Uptake NCT07313995NA14 sites📍 Arba Minch📍 Arba Minch📍 Arba Minch Arba Minch University · Tests: Digital health intervention A Systemic Screening for TB Disease in High-risk Groups in Barcelona NCT06706596n/a1 site📍 Badalona Fundació Institut Germans Trias i Pujol · Tests: Screening for TB symptoms, Chest X-ray Program for Rifampicin-Resistant Disease With Stratified Medicine for Tuberculosis NCT06441006Phase 2, Phase 36 sites📍 Ulaanbaatar📍 Kotri📍 Lima University of California, San Francisco · Tests: Bedaquiline, Linezolid, Pretomanid, Moxifloxacin, Control Arm FQ-S MDR/RR-TB regimen, designed according to latest inte… Effectiveness of Chat-based Mobile Application for Consultation (Zalo) in Improving Compliance With Follow-up Tests After Abnormal Chest X-ray Findings Interpret by Artificial Intelligent NCT07234929NA1 site📍 Ho Chi Minh City Gia Dinh People Hospital · Tests: chat-based mobile application (Zalo) Pre- and Post-treatment Lung Microbiota, Metabolome and Immune Signatures at the Site of Disease in Patients With Active Pulmonary Tuberculosis NCT04700579n/a3 sites📍 Cape Town📍 Cape Town📍 Cape Town University of Stellenbosch Respiratory Health and Wellbeing Post Pulmonary Tuberculosis NCT07178860n/a1 site📍 Liverpool Liverpool School of Tropical Medicine Risk Factors and Biomarkers for Post-tuberculosis Lung Damage NCT05426720n/a2 sites📍 Beijing📍 Beijing Peking University Third Hospital · Tests: no intervention
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy